Patents by Inventor M. Eric Gershwin

M. Eric Gershwin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8293280
    Abstract: A method for treatment of HIV infection includes administering at least one anti-HIV drug, such as a reverse transcriptase inhibitor, to a patient in need of such treatment and administering an extract from inflammatory tissue inoculated with vaccinia virus to the patient following the administration of the at least one anti-HIV drug. The extract maintains suppressive action on HIV replication, even if the administration of the anti-HIV drug is terminated.
    Type: Grant
    Filed: December 15, 2005
    Date of Patent: October 23, 2012
    Assignee: Nippon Zoki Pharmaceutical Co., Ltd.
    Inventors: Aftab A. Ansari, M. Eric Gershwin
  • Publication number: 20080112978
    Abstract: A method for treatment of HIV infection includes administering at least one anti-HIV drug, such as a reverse transcriptase inhibitor, to a patient in need of such treatment and administering an extract from inflammatory tissue inoculated with vaccinia virus to the patient following the administration of the at least one anti-HIV drug. The extract maintains suppressive action on HIV replication, even if the administration of the anti-HIV drug is terminated.
    Type: Application
    Filed: December 15, 2005
    Publication date: May 15, 2008
    Inventors: Aftab A. Ansari, M. Eric Gershwin
  • Publication number: 20050281839
    Abstract: The present invention provides a Spirulina composition capable of inhibiting the production of IL-4, and to an antiallergic food comprising the Spirulina composition, and also provides a method for prevention or improvement of allergic diseases, which includes ingestion of a composition comprising the Spirulina composition. The Spirulina composition contains Spirulina and a zinc compound, and the content of the zinc compound is from 0.04 to 5 parts by weight, in terms of zinc, based on 100 parts by weight of the dry weight of Spirulina. Ingestion of the Spirulina composition inhibits the production of IL-4, thus exerting the effect of preventing or improving allergic diseases. Also various foods comprising the Spirulina composition can be used as an antiallergic food because the effect of preventing or improving allergic diseases can be expected.
    Type: Application
    Filed: June 18, 2004
    Publication date: December 22, 2005
    Inventors: Amha Belay, M. Eric Gershwin
  • Publication number: 20040221327
    Abstract: The present invention provides a method of making an isolated human monoclonal antibody, said antibody binds a mitochondrial antigen bound by a human autoantibody found in patients with PBC. Said method involves using a transgenic non-human animal that has the ability to make human antibodies.
    Type: Application
    Filed: June 4, 2004
    Publication date: November 4, 2004
    Inventor: M. Eric Gershwin
  • Patent number: 5456912
    Abstract: Autoimmune diseases are controlled by the administration of non-methylene interrupted fatty acids of the formula ##STR1## in which R is alkyl or alkenyl. A preferred compound within the scope of this formula is 5,11,14-eicosatrienoic acid.
    Type: Grant
    Filed: December 28, 1993
    Date of Patent: October 10, 1995
    Assignee: The Regents of the University of California
    Inventors: J. Bruce German, M. Eric Gershwin, Alvin Berger